Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-08-19

Clinical Trial Update: Study of Lacosamide as an Adjunctive Drug Treatment for Epilepsy in Patients With Brain Tumors

View source ↗

Summary

A completed clinical trial evaluating lacosamide as an adjunctive therapy for epilepsy in patients with brain tumors; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lacosamide (Lacosamide)

Snippet

Sponsor: UCB BIOSCIENCES GmbH | Conditions: Brain Tumor Related Epilepsy (BTRE) | Status: COMPLETED | Results posted: 2019-08-19